KRT8P36

Across TCGA pan-cancer cohorts, KRT8P36 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated KRT8P36 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher KRT8P36 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated KRT8P36 expression acts as an unfavorable survival marker, although some lineages such as SKCM and UCEC show a favorable association.

MESO, KIRC, and LIHC are the cancer types where KRT8P36 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Median	III,IV	0.444	0.696	.003	53	view →
KIRC	DFS	Median	All	0.835	0.906	.006	51	view →
LIHC	OS	Median	III,IV	0.437	0.761	.001	48	view →
ACC	DFS	Median	IV	0.066	0.495	.001	43	view →
LUAD	OS	Median	All	0.764	0.854	<.001	37	view →
HNSC	OS	Median	All	0.211	0.509	<.001	36	view →
KICH	OS	Median	All	0.921	1.000	.008	35	view →
KIRP	OS	Tertile	All	0.548	0.901	.009	33	view →
SKCM	DFS	Median	IV	0.666	0.171	.001	27	view →
PAAD	OS	Quartile	All	0.460	0.758	.005	25	view →
CHOL	DFS	Median	All	0.164	0.716	<.001	20	view →
UCEC	DFS	Tertile	All	0.796	0.523	.001	20	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

KRT8P36–MESO (OS)

Open the MESO breakdown →